Humana Beats Q3 2026 Estimates as Revenue Rises 26% to $41.16B
Revenue of $41.16B vs. $40.87B expected and adjusted EPS of -$0.70 vs. -$1.00; revenue up 26% from a year earlier.
Humana (HUM) beat estimates for the third quarter of 2026 on both revenue and adjusted EPS. Revenue was $41.16 billion, up 26% from a year earlier, above the $40.87 billion estimate, and adjusted EPS was -$0.70 above the -$1.00 estimate.
Shares rose 1.2% in premarket trading as of 6:02 a.m. ET, to $416.55 from a $411.55 close.
Q3 2026 scorecard
| Parameters | Expected | Actual | Beat/Miss |
|---|---|---|---|
| Adjusted EPS | -$1.00 | -$0.70 | Beat by 30% |
| Revenue | $40.87B | $41.16B | Beat by 0.7% |
| Change | YoY | QoQ |
|---|---|---|
| Adjusted EPS | ▼ from $3.24 | ▼ from $7.61 |
| Revenue | ▲ 26% | ▲ 0.7% |
By our calculation, revenue was $282.0 million above the estimate and adjusted EPS was $0.30 above it. The QoQ column compares with the previous quarter's revenue of $40.87 billion and adjusted EPS of $7.61. The YoY column compares with $32.65 billion and $3.24 in the same quarter a year earlier.
Track record
- EPS record. Adjusted EPS beat the estimate in 8 of the last 8 reports, including this one.
- Revenue record. Revenue beat the estimate in 7 of the last 8 reports.
- Revenue trend. Revenue over the last 5 reports, oldest first: $32.65 billion, $32.52 billion, $39.65 billion, $40.87 billion and $41.16 billion.
What to watch
- Next-quarter estimates. Consensus calls for EPS of -$7.84 and revenue of $41.21 billion next quarter, based on 16 analysts.
- Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 26% increase to $41.16 billion.
- Estimate record. Whether Humana extends a record of beating EPS estimates in 8 of its last 8 reports.
- Related coverage. See our reports on Fluor, Kyivstar, National HealthCare and Pacira BioSciences.
Sources: Results are from Humana's Nov. 6, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Humana's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.
Readers also read
MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.